Olmesartan Medoxomil is an angiotensin II receptor (AT1) antagonist. This compound also inhibits the negative regulatory feedback on renin secretion. The result of receptor inhibition is vasodilation and a reduction in peripheral resistance.
Olmesartan Medoxomil
Description | |
---|---|
(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 5-(2-hydroxypropan-2-yl)-2-propyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylate | |
144689-63-4 | |
C24H26N6O3 | |
OMST;CS-866;Olmetec;Benicar;Oimesartan;Olmesartan medoxomil;OLMESARTAN MEDOXIMIL;OlmesartanC29H30N6O6;Sanguisorba officinalis L.;Olmesartan Medoxomil (100 mg) | |
Angiotensin II Receptor Antagonist |